Victoza vs Saxenda
Victoza (liraglutide) and Saxenda (liraglutide) contain the same active drug, but they are approved for completely different indications and are prescribed at different doses. Victoza is approved to manage blood sugar levels in people with type 2 diabetes, while Saxenda is approved at a higher dose specifically for chronic weight management in adults and adolescents with obesity or overweight.
Shop Medications
Because both medications share the same active ingredient, many patients wonder if they can simply swap one for the other. While their biological mechanism is identical, the dosing schedules, target conditions, and insurance coverage pathways are distinct. Understanding how these two daily injections compare can help you make sense of your prescription and discuss the right treatment plan with your doctor.
In This Article
- What Is the Main Difference Between Victoza and Saxenda?
- How Does Victoza Work for Type 2 Diabetes?
- How Does Saxenda Work for Weight Loss?
- How Do the Dosing Schedules Compare in Victoza vs Saxenda?
- Can You Take Victoza for Weight Loss or Saxenda for Diabetes?
- Can You Substitute Victoza and Saxenda for Each Other?
- What Are the Common Side Effects of Victoza and Saxenda?
- What Are the Serious but Rare Side Effects?
- How Do Insurance and Cost Differ for Victoza vs Saxenda?
- Which Medication Is Right for You?
- References
What Is the Main Difference Between Victoza and Saxenda?
The main difference between Victoza and Saxenda is their approved medical use and maximum daily dose. Victoza is approved to treat type 2 diabetes at doses up to 1.8 milligrams per day, while Saxenda is approved for chronic weight management at a higher dose of 3.0 milligrams per day.
Both medications are manufactured by Novo Nordisk and belong to a class of medications known as glucagon-like peptide-1 receptor agonists, often called GLP-1 receptor agonists for short. GLP-1 is a natural hormone that your gut releases after you eat. It stimulates insulin production, slows down how fast your stomach empties food into your intestines, and signals fullness to your brain. Even though both brand names deliver this same active molecule into your body, regulatory agencies evaluate them under separate standards based on clinical trial goals.

Why Pay Full Price?
Search our full medication catalogue and save up to 80% - no insurance needed.
See Prices NowBecause their dosing pens deliver different amounts of medication, each product is packaged to align with its intended treatment schedule. A Victoza prefilled pen can deliver doses of 0.6 milligrams, 1.2 milligrams, or 1.8 milligrams. A Saxenda prefilled pen delivers doses of 0.6 milligrams, 1.2 milligrams, 1.8 milligrams, 2.4 milligrams, or 3.0 milligrams. Using one pen to try to achieve the other medication dosing schedule can lead to dosing errors or running out of medication unexpectedly.
How Does Victoza Work for Type 2 Diabetes?
Victoza works by mimicking the natural hormone GLP-1, which helps your pancreas release the right amount of insulin when your blood sugar rises after meals. It also lowers glucagon, a hormone that causes your liver to release stored sugar into your bloodstream.
In addition to regulating insulin and glucagon, Victoza slows gastric emptying. This means food leaves your stomach more gradually, preventing sharp spikes in glucose levels following a meal. For individuals living with type 2 diabetes, this combined action significantly lowers hemoglobin A1c, which is a key lab test that measures average blood sugar over a three-month window.
Victoza also carries an official indication to reduce the risk of major adverse cardiovascular events, such as heart attack, stroke, or cardiovascular death, in adults with type 2 diabetes who have established cardiovascular disease. Patients starting Victoza usually begin at 0.6 milligrams once daily for one week to help their digestive system adjust. Their doctor then increases the dose to 1.2 milligrams daily, and if additional blood sugar control is needed, up to a maximum dose of 1.8 milligrams once daily. While patients frequently lose weight on Victoza due to its effect on appetite, it is not formally labeled or dosed as a weight loss drug.
How Does Saxenda Work for Weight Loss?
Saxenda works by targeting the appetite centers in your brain to decrease hunger, increase sensations of fullness, and slow stomach emptying so you eat fewer calories throughout the day. It is prescribed alongside a reduced-calorie diet and increased physical activity for chronic weight management.
To qualify for Saxenda, an adult typically needs a body mass index of 30 or greater, which is classified as obesity, or a body mass index of 27 or greater, which is classified as overweight, along with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is also approved for pediatric patients aged twelve and older who have a body weight above 60 kilograms and a body mass index corresponding to obesity.
Reaching the therapeutic weight management dose requires a slow, weekly titration process to minimize gastrointestinal discomfort. Patients start at 0.6 milligrams once daily for the first week. Every seven days, the daily dose increases by 0.6 milligrams until reaching the maintenance dose of 3.0 milligrams daily by week five. Clinical studies show that lower daily doses of liraglutide, such as the 1.2 milligram or 1.8 milligram doses used in diabetes management, do not provide the same sustained, clinically meaningful weight reduction as the full 3.0 milligram dose.
How Do the Dosing Schedules Compare in Victoza vs Saxenda?
The dosing schedules for Victoza and Saxenda both start at 0.6 milligrams once daily, but Saxenda continues to step up every week until reaching 3.0 milligrams, whereas Victoza stops titration at either 1.2 milligrams or 1.8 milligrams. Neither medication should ever be taken together or combined with other GLP-1 receptor agonists.1
Both medications are administered once every day as a subcutaneous injection, which means an injection just under the skin. Common injection sites include the abdomen, the front of the thigh, or the upper arm. The injection can be taken at any time of day, with or without food, though choosing a consistent time each day helps maintain steady medication levels in your system.
Here is how the standard step-up schedules compare week by week:
- Week one: Both medications start at 0.6 milligrams once daily to give the stomach time to adjust.
- Week two: Both medications step up to 1.2 milligrams once daily. For many Victoza patients, this serves as their long-term maintenance dose.
- Week three: Victoza may increase to its maximum dose of 1.8 milligrams daily if blood sugar requires it, while Saxenda increases to 1.8 milligrams daily as a stepping stone.
- Week four: Victoza remains at 1.8 milligrams, while Saxenda steps up to 2.4 milligrams once daily.
- Week five and beyond: Saxenda reaches its full target maintenance dose of 3.0 milligrams once daily, while Victoza remains at either 1.2 milligrams or 1.8 milligrams.
Because the maximum dose of Saxenda is significantly higher, patients using Saxenda use up pens more quickly. A single package of five pens lasts thirty days once you are stable on the 3.0 milligram daily dose. For Victoza, a two-pen or three-pen box can last anywhere from one to two months, depending on whether your daily dose is 1.2 milligrams or 1.8 milligrams.
Can You Take Victoza for Weight Loss or Saxenda for Diabetes?
You should not take Saxenda strictly for blood sugar control, nor should you expect Victoza to produce the robust weight loss seen in clinical trials for Saxenda. The Food and Drug Administration has not approved Victoza for weight management, and the official labeling notes that liraglutide doses below 3.0 milligrams daily have not been shown to produce sufficient long-term weight reduction.
While individuals taking Victoza for type 2 diabetes often experience modest weight loss as an added benefit, the primary clinical goal of that treatment is glycemic control. Multiple clinical meta-analyses demonstrate that higher doses of liraglutide produce substantially more weight loss than lower doses. Systematic reviews analyzing liraglutide in adults without diabetes confirm that the 3.0 milligram daily dose delivered by Saxenda is necessary to generate significant reductions in total body weight, waist circumference, and body mass index.
Conversely, while Saxenda does improve glycemic markers and hemoglobin A1c in people who have prediabetes or type 2 diabetes alongside obesity, it is not licensed as a diabetes medication. Health care providers avoid prescribing Saxenda solely for blood sugar management because insurance plans rarely approve obesity-labeled drugs for diabetes care.
Can You Substitute Victoza and Saxenda for Each Other?
No, Victoza and Saxenda are not interchangeable, and a pharmacist cannot legally substitute one for the other without a new prescription from your doctor. Even though they contain the identical molecule, their pen delivery systems, dosing increments, and approved clinical uses are entirely separate.
This separation between diabetes and weight management brands is common among GLP-1 medications. For instance, semaglutide is sold as Ozempic (semaglutide) for type 2 diabetes and as Wegovy (semaglutide) for chronic weight management. Similarly, tirzepatide is sold as Mounjaro (tirzepatide) for type 2 diabetes and as Zepbound (tirzepatide) for weight loss. In every case, regulators require separate brand names and dosing protocols for diabetes versus obesity care.
What Are the Common Side Effects of Victoza and Saxenda?
The most common side effects of both Victoza and Saxenda involve the digestive tract, including nausea, diarrhea, constipation, vomiting, decreased appetite, and stomach discomfort. These symptoms occur frequently because liraglutide slows down how quickly food empties from your stomach.
Because Saxenda escalates to a higher daily dose, gastrointestinal side effects are often reported at slightly higher rates during Saxenda titration than during Victoza therapy. Clinical studies show that digestive symptoms are most intense during the initial weeks of treatment or immediately following a dose increase, after which they usually lessen as your body becomes accustomed to the medication.
Patients can minimize these common side effects by adopting simple dietary habits:
- Eat smaller meals: Stop eating as soon as you begin to feel satisfied rather than waiting until you feel full.
- Stay hydrated: Drink plenty of water throughout the day, especially if you experience mild nausea or diarrhea.
- Avoid greasy foods: Limit heavy, fried, or high-fat meals, which can worsen stomach fullness and delay digestion further.
- Follow the titration schedule: Never rush your weekly dose increase, and speak with your doctor about staying at a lower dose for an extra week if nausea becomes difficult to manage.
What Are the Serious but Rare Side Effects?
Serious but rare side effects associated with liraglutide include pancreatitis, gallbladder disease such as gallstones, acute kidney injury from severe dehydration, and serious allergic reactions. Both medications carry a boxed warning regarding the potential risk of thyroid C-cell tumors based on findings observed in animal studies.
Inflammation of the pancreas, known as pancreatitis, is reported in less than one percent of patients taking liraglutide. If you experience persistent, severe pain in your upper abdomen that radiates toward your back, accompanied by nausea or vomiting, you should stop taking the medication and seek emergency medical care immediately.
Because of the findings regarding thyroid C-cell tumors in rodent studies, both Victoza and Saxenda are strictly contraindicated in individuals with a personal or family history of medullary thyroid carcinoma, as well as in patients with Multiple Endocrine Neoplasia syndrome type 2. Additionally, if you take Victoza alongside insulin or an insulin secretagogue such as a sulfonylurea, your risk of hypoglycemia, or low blood sugar, increases. Your doctor may lower your insulin dose when starting liraglutide to protect against dangerous blood sugar drops.
How Do Insurance and Cost Differ for Victoza vs Saxenda?
Insurance coverage differs significantly between the two drugs because commercial and government health plans routinely cover medications for type 2 diabetes like Victoza, but many plans exclude coverage for weight loss medications like Saxenda. As a result, patients prescribed Saxenda frequently face much higher out-of-pocket costs than those prescribed Victoza.
Health insurance formularies typically categorize obesity treatments under lifestyle or elective coverage tiers, meaning patients must submit complex prior authorization requests or pay the retail cash price entirely on their own. Even when an insurer does agree to cover Saxenda, the monthly co-pay or coinsurance fee can be substantial.
When insurance denies coverage or leaves you with high deductibles, navigating prescription costs can feel overwhelming. Patients seeking predictable and affordable prices often look into safe, accredited international mail-order services. You can explore safe, reliable cash-pay options through Universal Drugstore, which helps individuals find genuine medications at significantly reduced out-of-pocket rates when domestic insurance coverage falls short.
Which Medication Is Right for You?
The right medication depends directly on your health diagnosis, your treatment goals, and your medical history. If your primary medical need is lowering blood sugar to manage type 2 diabetes or reducing cardiovascular risk, Victoza is the appropriate choice. If your main goal is substantial, long-term weight reduction to treat obesity or weight-related complications without uncontrolled diabetes, Saxenda may be right for you.
Your physician will review your baseline body mass index, blood glucose history, cardiovascular health, and insurance situation before recommending either prescription. By having an open conversation with your doctor about your health goals and budget, you can choose the therapy that provides the greatest benefits for your everyday wellness.
References
- Victoza (liraglutide) [package insert]. Novo Nordisk Inc; 2024. Accessed November 9, 2026. Accessed November 7, 2026.
- Saxenda (liraglutide) [package insert]. Novo Nordisk Inc; 2025. Accessed November 9, 2026.
- Konwar M, et al. Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis. Int J Clin Pract. 2022 Jul 19;2022:1201977. Accessed November 7, 2026.
- Zhang P, Liu Y, Ren Y, Bai J, Zhang G, Cui Y. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis. Afr Health Sci. 2019 Sep;19(3):2591-2599. Accessed November 7, 2026.
- Alsanea S, Alkofide H, Almadi B, Almohammed O, Alwhaibi A, Alrabiah Z, Kalagi N. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis. Endocr Pract. 2024 Aug;30(8):737-745. Accessed November 7, 2026.